NASDAQ · ALFUW

Centurion Acquisition Corp.

$0.24 +$0.02 (+7.32%) 1D

Key Metrics

Market cap
P/E · TTM
Revenue · TTM
$11.36M
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y -1.43
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 12
    The stock moved +100.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 12
  • Apr 21
    The stock moved +49.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 21
  • Apr 20
    From its Jan 29 high, the share price fell 70%.

    Peak close $0.27 on Jan 29; trough close $0.08 on Apr 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -70%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.08 – $0.45
Avg volume · 20D35.3K
Net cash
Book value / share
IndustryBlank Checks
ExchangeNASDAQ
About Centurion Acquisition Corp.
IPO dateAug 1, 2024
Employees3

Centurion Acquisition Corp is a blank check company.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -85.0% · —

Financial Health

Current ratio0.35
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital−$101.34K

Cash Flow · TTM

Operating CF −$463.43K
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings